UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer

Modern pathology, 2020-09, Vol.33 (9), p.1746-1752

2020

Link zum Volltext

Verfügbarkeit prüfen

Antibody validation for protein expression on tissue slides: a protocol for immunohistochemistry

BioTechniques, 2020-12, Vol.69 (6), p.460-468

2020

Link zum Volltext

Verfügbarkeit prüfen

Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood

Clinical epigenetics, 2019-04, Vol.11 (1), p.59-59, Article 59

2019

Link zum Volltext

Verfügbarkeit prüfen

Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study

Breast cancer research : BCR, 2021-12, Vol.23 (1), p.113-113, Article 113

2021

Link zum Volltext

Verfügbarkeit prüfen

Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms

EBioMedicine, 2022-08, Vol.82, p.104143-104143, Article 104143

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract PD5-01: Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays in triple negative breast cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.PD5-01-PD5-01

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-03-01: Budding Tumorigenesis: A novel proposed model for breast cancer tumorigenesis

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P4-P4-03-01

2022

Link zum Volltext

Verfügbarkeit prüfen

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Laboratory investigation, 2022-10, Vol.102 (10), p.1101-1108

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS2-03: Comparison of pathologist reads of sp142 and sp263 with quantitative measurement of protein and mRNA in triple negative breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS2-03-PS2-03

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4973: Comparison of tumor immune microenvironment in triple negative breast cancer (TNBC) of African American versus that of white patients

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4973-4973

2020

Link zum Volltext

Verfügbarkeit prüfen

Use of distinct molecular signatures of appendiceal cancer subtypes to assess biomarker development

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.189-189

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2842: Vesal Yaghoobi

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2842-2842

2019

Link zum Volltext

Verfügbarkeit prüfen

Quantitative assessment of immune cell populations and associations with clinical outcomes in African-American (AA) versus Caucasian triple-negative breast cancer (TNBC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14180-e14180

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (11), p.1922-1935

2021

Link zum Volltext

Verfügbarkeit prüfen

Advances in quantitative immunohistochemistry and their contribution to breast cancer

Expert review of molecular diagnostics, 2020-05, Vol.20 (5), p.509-522

2020

Link zum Volltext

Verfügbarkeit prüfen

Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer

Laboratory investigation, 2022-10, Vol.102 (10), p.1143-1149

2022

Link zum Volltext

Verfügbarkeit prüfen

Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer

Clinical cancer research, 2022-06, Vol.28 (12), p.2587-2597

2022

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling

Journal of thoracic oncology, 2022-08, Vol.17 (8), p.991-1001

2022

Link zum Volltext

Verfügbarkeit prüfen

Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas

Journal of neuropathology and experimental neurology, 2021-02, Vol.80 (2), p.150-159

2021

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Assessment of Siglec-15 Expression in Lung, Breast, HNSCC and Bladder Cancer

Laboratory investigation, 2022-05, Vol.102 (10), p.1143-1149

2022

Link zum Volltext

Verfügbarkeit prüfen

Development of an immunohistochemical assay for Siglec-15

Laboratory investigation, 2022-07, Vol.102 (7), p.771-778

2022

Link zum Volltext

Verfügbarkeit prüfen

Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer

Clinical cancer research, 2021-11, Vol.27 (22), p.6156-6163

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-09-05: Predictive markers of response to durvalumab concurrent with nab-paclitaxel and dose dense doxorubicin cyclophosphamide (ddAC) neoadjuvant therapy for triple negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-09-05

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 339: Resistance to trastuzumab is associated with alpha-smooth muscle actin expression in the stroma of patients with HER2+ breast cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.339-339

2021

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the tumor immune microenvironment of triple-negative breast cancer (TNBC) patients who self-identify as African American (AA) or non-African American (NonAA)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.564-564

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Humans
(15)
Oncology
(10)
Female
(6)
Pathology
(6)
Breast Cancer
(5)
Immunohistochemistry
(5)
Immunotherapy
(5)
Tumors
(5)
Antibodies
(4)
B7-H1 Antigen - Metabolism
(4)
Biomarkers
(4)
Carcinoma, Non-Small-Cell Lung - Pathology
(4)
Immunofluorescence
(4)
Lung Cancer
(4)
Patients
(4)
Pd-L1 Protein
(4)
Tumor Microenvironment
(4)
Breast Neoplasms - Genetics
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer

Antibody validation for protein expression on tissue slides: a protocol for immunohistochemistry

Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood

Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study

Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms

Abstract PD5-01: Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays in triple negative breast cancer

Abstract P4-03-01: Budding Tumorigenesis: A novel proposed model for breast cancer tumorigenesis

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Abstract PS2-03: Comparison of pathologist reads of sp142 and sp263 with quantitative measurement of protein and mRNA in triple negative breast cancer

Abstract 4973: Comparison of tumor immune microenvironment in triple negative breast cancer (TNBC) of African American versus that of white patients

Use of distinct molecular signatures of appendiceal cancer subtypes to assess biomarker development

Abstract 2842: Vesal Yaghoobi

Quantitative assessment of immune cell populations and associations with clinical outcomes in African-American (AA) versus Caucasian triple-negative breast cancer (TNBC)

Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas

Advances in quantitative immunohistochemistry and their contribution to breast cancer

Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer

Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer

Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling

Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas

Quantitative Assessment of Siglec-15 Expression in Lung, Breast, HNSCC and Bladder Cancer

Development of an immunohistochemical assay for Siglec-15

Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer

Abstract P3-09-05: Predictive markers of response to durvalumab concurrent with nab-paclitaxel and dose dense doxorubicin cyclophosphamide (ddAC) neoadjuvant therapy for triple negative breast cancer (TNBC)

Abstract 339: Resistance to trastuzumab is associated with alpha-smooth muscle actin expression in the stroma of patients with HER2+ breast cancer

Characterization of the tumor immune microenvironment of triple-negative breast cancer (TNBC) patients who self-identify as African American (AA) or non-African American (NonAA)

Suchergebnisse filtern